Column Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-895
Closed -$44K 748
2022
Q1
$44K Hold
895
0.01% 308
2021
Q4
$50K Sell
895
-1,015
-53% -$55.8K 0.01% 298
2021
Q3
$111K Sell
1,910
-64
-3% -$3.94K 0.02% 176
2021
Q2
$125K Sell
1,974
-266
-12% -$17.5K 0.03% 162
2021
Q1
$143K Sell
2,240
-834
-27% -$48.4K 0.03% 145
2020
Q4
$161K Buy
3,074
+1,146
+59% +$56.5K 0.04% 126
2020
Q3
$84K Hold
1,928
0.03% 175
2020
Q2
$84K Buy
1,928
+298
+18% +$12.6K 0.03% 169
2020
Q1
$63K Buy
1,630
+109
+7% +$5.55K 0.03% 172
2019
Q4
$86K Buy
+1,521
New +$84.8K 0.04% 165

Other funds holding XRAY

Column Capital Advisors's XRAY Position: Q2 2022 in Review

Column Capital Advisors sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 895 shares — an estimated $44K sold.

Column Capital Advisors first reported a position in XRAY in Q4 2019 and held it in 10 quarters. The position peaked at $161K in Q4 2020. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Column Capital Advisors reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Column Capital Advisors sold 895 Dentsply Sirona shares in Q2 2022, an estimated $44K.
  • Column Capital Advisors first reported a position in Dentsply Sirona in Q4 2019 and held it in 10 quarters.
  • Column Capital Advisors's Dentsply Sirona position peaked at $161K in Q4 2020.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Column Capital Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.